Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 28.70B |
| Enterprise value | 31.45B |
| Trailing P/E | 14.14 |
| Forward P/E | 12.29 |
| PEG ratio (5-yr expected) | 14.81 |
| Price/sales (ttm) | 2.74 |
| Price/book (mrq) | 2.42 |
| Enterprise value/revenue | 2.96 |
| Enterprise value/EBITDA | 10.07 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.42 |
| 52-week change 3 | -31.00% |
| S&P500 52-week change 3 | -16.88% |
| 52-week high 3 | 291.54 |
| 52-week low 3 | 187.16 |
| 50-day moving average 3 | 209.11 |
| 200-day moving average 3 | 212.86 |
Share statistics
| Avg vol (3-month) 3 | 906.21k |
| Avg vol (10-day) 3 | 1.08M |
| Shares outstanding 5 | 145.11M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 144.67M |
| % held by insiders 1 | 0.69% |
| % held by institutions 1 | 86.46% |
| Shares short (30 Aug 2022) 4 | 1.89M |
| Short ratio (30 Aug 2022) 4 | 2.53 |
| Short % of float (30 Aug 2022) 4 | 1.47% |
| Short % of shares outstanding (30 Aug 2022) 4 | 1.30% |
| Shares short (prior month 28 Jul 2022) 4 | 1.94M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 3:1 |
| Last split date 3 | 17 Jan 2001 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Jun 2022 |
Profitability
| Profit margin | 19.36% |
| Operating margin (ttm) | 27.78% |
Management effectiveness
| Return on assets (ttm) | 7.45% |
| Return on equity (ttm) | 13.65% |
Income statement
| Revenue (ttm) | 10.63B |
| Revenue per share (ttm) | 72.36 |
| Quarterly revenue growth (yoy) | -6.70% |
| Gross profit (ttm) | 8.87B |
| EBITDA | 3.5B |
| Net income avi to common (ttm) | 2.06B |
| Diluted EPS (ttm) | 13.79 |
| Quarterly earnings growth (yoy) | 135.90% |
Balance sheet
| Total cash (mrq) | 4.8B |
| Total cash per share (mrq) | 33.06 |
| Total debt (mrq) | 7.55B |
| Total debt/equity (mrq) | 63.65 |
| Current ratio (mrq) | 1.94 |
| Book value per share (mrq) | 81.77 |
Cash flow statement
| Operating cash flow (ttm) | 2.54B |
| Levered free cash flow (ttm) | 2.1B |
© 2022 Yahoo. All rights reserved.
